Agreement between definitions of pharmaceutical opioid use disorders and dependence in people taking opioids for chronic non-cancer pain (POINT): a cohort study

Grants

Funding Acknowledgements

This study received funding from the Australian National Health and Medical Research Council (NHMRC; 1022522). LD, BL, SN, and WH are supported by NHMRC research fellowships (1041472, 1073858, 1013803, and 569738, respectively). The National Drug and Alcohol Research Centre (NDARC) at University of New South Wales (Sydney, Australia) is supported by funding from the Australian Government under the Substance Misuse Prevention and Service Improvements Grant Fund. We thank POINT participants who were willing to share their experiences with us. We thank Bianca Hoban, Ranira Moodley, Kimberley Smith, Jessica Belcher, Sarah Freckleton, Anika Martin, and Rachel Urquhart-Secord from the NDARC for their contribution to data collection. We thank Mary Kumvaj, NDARC archivist, for her work in developing the logic for and carrying out the systematic literature search. We thank the Pharmacy Guild of Australia, the New South Wales Pharmacy Guild, and Pain Australia, for their support of this study and assistance with dissemination. We also thank the POINT advisory committee for their advice on the design and conduct of the study.